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INTRODUCTION
According to the Alzheimer's Disease Association, there were 36 million people who suffered from dementia worldwide in 2010. This number is expected to be 115 million by 2050 for the global aging population. [1] Therefore there is an urgent need to develop effective drugs that can prevent, slow down the disease progression and hopefully cure the disease. β-Amyloid (Aβ) peptides i.e., Aβ and Aβ , are the principal protein components of Aβ plaques found in the brains of Alzheimer's disease (AD) patients by autopsy. The occurrence of the Aβ plaques, considered as a cardinal feature of AD, provides the only confirmed diagnosis of the disease. Extensive research in past decades has evidenced that the Aβ peptides play a central role in the disease progression, in which Aβ peptides assemble into aggregates that exert cytotoxic effects towards neurons and initiate the pathogenic cascade, i.e. the amyloid cascade hypothesis. [2; 3] Recent studies showed that oligomeric, prefibrillar and diffusible assemblies of Aβ peptides are particularly deleterious. [4] The underlying mechanism of Aβ neurotoxicity however is very complex. Evidences show that it involves a glutamate receptor subtype, glutamate release, N-methyl-D-aspartate (NMDA) receptor, an increase in intracellular Ca 2+ ion concentration as well as an elevation in oxidative stress.
Thus, compounds that can (i) inhibit Aβ aggregation formation; (ii) protect cells against
reactive oxygen species toxicity and; (iii) reduce Ca 2+ ion influx induced by Aβ species are promising approaches to prevent and treat AD. Chinese herbal medicines (CHMs) have been used to treat AD patients for a long time although the efficacy and safety of its formulation is still not conclusive. Various types of compounds have been identified, such as oligopeptides, polyphenols, anti-oxidants and anti-inflammatory drugs, and are reported to be Aβ-aggregation inhibitors that provide neuroprotection. [5] [6] [7] [8] [9] [10] [11] While this thematic issue reported other two kinds of curcumin derivatives [12] [13] and iridium complex [14] and rhodium complex [15] as effective inhibitors of Aβ aggregation.
CHMs could be a good source of single components for the therapeutic treatment of AD. As inflammation and oxidation stress are shown to be highly related to AD, it would be interesting to investigate the roles of CHMs that are known to have anti-inflammatory and anti-oxidant effect, in AD treatment. For examples, albiflorin is one of the natural components found in Paeoniae radix, [16] which is an important crude drug used in traditional Chinese medicines (TCMs) for treating abdominal pain and wounds. [17] Aloeemodin is an anthraquinone derivative that is extracted from the root and rhizome of Rheum palmatum. Its anti-cancer effect has been demonstrated. [18] Neohesperidin obtained from Poncirus trifoliata shows protection on gastric cancer cells. [19] Physcion is an ingredient found in the roots of the Chinese rhubarb named Rheum officinale Baill which was shown to have antimicrobial activity. [20] In this study, we have screened more than 35 single compounds extracted from CHMs for inhibition of Aβ aggregation and investigated the potential of the four potent inhibitors for AD prevention and treatment. We studied (i) their inhibitory effect on Aβ aggregation by fluorescence microscopy, Thioflavin T fluorescence assay and circular dichroism measurement; (ii) their neuroprotective effect on primary hippocampal cells; (iii) their influence on ROS generation induced by the monomeric and oligomeric Aβ species; and (iv) the change in the intracellular Ca 2+ ion concentration in response to Aβ 1-42.
MATERIALS AND METHODS

Animals
Pregnant SD rats were purchased from the Laboratory Animal Services Center, the Chinese University of Hong Kong, Hong Kong. The animals were fed with a standard rodent diet ad libitum with free access to water and were housed in rooms maintained at 22 ± 1 °C with a 12 hour light/dark cycle (lights on 6:00-18:00). The pregnant rats were acclimated to the facility for 1 week before giving birth. The Animal Ethics Committee of Hong Kong Baptist University, approved all experimental protocols, in accordance with "Institutional Guidelines and Animal Ordinance" from Department of Health of Hong Kong Special Administrative
Region.
Chemicals and reagents
Compounds of CHMs screened in this study including albiflorin, aloeemodin, amygdalin, astragaloside IV, atractylenolide III, baicalin, benzoylgomisin Q, calycosin, 
Transmission electron microscopy (TEM) imaging
Sample solution of 5 μL was applied on a carbon-coated copper grid (Electron Microscopy Science, USA) and dried at room temperature. The sample was then negative stained with 0. 
Circular Dichroism (CD) Measurement
The CD spectra of 50 μM monomeric Aβ 1-42 solution in the presence or absence of the CHMs were obtained by a Jasco J-810 Circular Dichroism Spectropolarimeter in a spectral range of 180-260 nm using a 1-mL quartz cell. The bandwidth and the scan speed were set at 1 nm and 200 nm/min respectively. Each spectrum was an average of three individual measurements.
Spectra were smoothed with Savitzky-Golay smoothing by OriginPro 8 software.
Primary Cell Isolation and Culture
Seven day-old SD rats were euthanized with CO 2 , and the hippocampus tissues were harvested quickly. Neuronal cells were isolated as described previously with modification.
[23] Briefly, the hippocampus tissues were washed with DMEM/F12 medium (Gibco, USA) with 10 % fetal bovine serum (Gibco Life, USA) for three times and then digested in DMEM/ F12 medium containing 2 mg/mL papain (SIGMA, USA) at 37 °C for 20 min under gentle shaking. The tissues were then dispersed using 3 mL transfer pipette (SIGMA, USA) and the solution was filtered by a 0.4 µm nylon filter (BD falcon). The filtrate was further subjected to centrifugation at 1000 rpm for 5 min. The pellet containing the dissociated neurons was and incubated at 37 °C, under 80 % humidity and 5 % CO 2 . Cytosine of 1 μM was added into the culture medium on the day after cell isolation and removed the next day by changing medium. Culture medium was changed every 3 days, and the cells were treated with designated drugs after 7 days in culture.
Cell line
Cell line SH-SY5Y (Cat. Number CRL2266, ATCC, USA）were cultured in DMEM/F12
supplemented with 10 % fetal bovine serum and 0.25 % PSN. The cells were incubated in humidified incubator at 37 °C with 5 % CO 2 .
Cytotoxicity and viability assays
Viability 
Measurement of reactive oxygen species (ROS) generation
The effect of each herbal compound on intracellular ROS formation was evaluated by the 
Circular dichroism studies
In order to gain insight into the mechanism of the inhibitory effect of these compounds, circular dichroism (CD) spectra were measured to investigate the conformational changes of monomeric Aβ 1-42 upon mixing with these compounds. The process of Aβ aggregation is believed to result from the conformation change of Aβ peptides from a random coil α-helix conformer to the amyloidogenic β-sheet conformer that causes the favorable self-assembly of the peptides to neurotoxic intermediates and Aβ plaques. The CD spectra of the Aβ peptides with or without the CHMs were shown in Figure 3c . In the absence of the CHM compounds, monomeric Aβ 1-42 showed a negative CD signal at 219 nm which is the characteristic wavelength of the β-sheet conformation. [29] Upon addition of the CHM components, the β-sheet character peak was significantly diminished. The peak shifted from 219 to 225 nm for albiflorin, aloeemodin and physcion while the peak for neohesperidin further shifted to 230 nm. The alterations in peak amplitude and position indicated that the population of β-sheet conformer was dramatically reduced and meanwhile a new conformation, Aβ-CHM complex, was established.
Cytotoxicity of CHMs by MTT assays
The cytotoxicity of the compounds from CHMs were determined by a MTT assay on human SH-SY5Y neuroblastoma cells. Cell cultures were treated with CHMs in a concentration range from 0.1 to 50 μM for 24 hours before the MTT assays. As depicted in Figure 4 , these four compounds are generally of low toxicity in the micro-molar range. Physcion is relatively toxic among the four selected compounds. The survival of the cells dropped to about 55 % at 10 μM of physcion. However, the cell mortality was less than 15 % for the remaining three compounds at a concentration of 10 μM. Therefore, albiflorin, aloeemodin and neohesperidin being non-toxic to neuronal cells were further investigated for their clinical potential using primary hippocampal cells. Fig. (4) . Toxicity of albiflorin, aloeemodin, neohesperidin and physcion on human SH-SY5Y neuroblastoma cells as determined by an MTT assay. Cells were exposed to CHMs of various concentrations for 24 hours.
Neuroprotection on primary hippocampal cells
The toxicity of the monomeric and oligomeric Aβ species on primary hippocampal cells was measured by an MTT assay after incubation of 24 hours. Consistent with the literature, it was found and that the toxicity of Aβ 1-42 was higher than that of Aβ , and that the oligomeric form was more toxic than the monomeric form. Among the four potent inhibitors, albiflorin, aloeemodin and neohesperidin were chosen for an investigation of neuroprotection effect because of their low cytotoxicity. The primary hippocampal cells were co-incubated with each of these compounds and the monomeric Aβ in a 1:1 molar ratio (10 μM). The mortality of the cells in the presence of both these inhibitors and Aβ species relative to that treated by Aβ species alone is depicted in Figure 5a . It was found that all three CHM compounds provided protection against monomeric Aβ-induced toxicity. In another similar experiment, the primary hippocampal cells were incubated for 24 hours with the oligomeric form of Aβ and Aβ , with and without the three CHM compounds. The MTT results are depicted in Figure 5b . It is worthy to note that aloeemodin is the most potent compound at protecting neuronal cells against both oligomeric Aβ 1-40 -and Aβ 1-42 -induced neurotoxicity. 
Reactive oxygen species (ROS) measurement
It has been demonstrated that one of the toxic effects induced by Aβ species is the production of intracellular reactive oxygen species (ROS). The effect of the neuroprotective inhibitors, albiflorin, aloeemodin and neohesperidin was determined by ROS measurement with the 2',7'-dichlorofluorescein (DCF) fluorescence assay. Primary hippocampal cells were incubated with monomeric Aβ peptides with and without the three compounds from CHMs for 24 hours. The final concentration of the Aβ peptides and the CHMs was kept as 10 µM.
As illustrated in Figure 6A , aloeemodin showed consistent attenuation against Aβ induced ROS generation on primary hippocampal cells while albiflorin and neohesperidin did not.
These results implied that these three compounds from various CHMs protect the hippocampal neuron cells through different pathways. Similarly, primary hippocampal cells were incubated with preformed oligomeric Aβ and Aβ in the presence and absence of the three compounds for 24 hours. The fluorescence intensity of the ROS indicator, DCF, in the presence of the preformed oligomeric Aβ was doubled compared to the control cells (without treatment) indicating the oxidative stress induced by Aβ aggregates. However, the ROS production was obviously suppressed by the three compounds of CHMs. As shown in Figure 6B , albiflorin and neohesperidin were able to cut down the ROS level by about 50 %.
These results suggest that these two compounds are powerful in protecting neuronal cells by reducing the ROS level as induced by the oligomeric Aβ species. 
Calcium(II) ion imaging
The neurotoxic Aβ induces overloading of intracellular Ca 2+ and thus could result in cell death. [28] To explore the influence of the three neuroprotective compounds from CHMs on the calcium influx induced by Aβ , the primary hippocampal cells were pre-treated with the CHMs for 30 min before the addition of Aβ 1-42 . The calcium concentration was then monitored by fluo-4 AM. As depicted by Figure 7 , the intracellular Ca 2+ concentration rapidly increased upon the treatment of 10 μM Aβ , and it showed higher fluorescence intensity compared with those pretreated with the compounds. For those primary hippocampal neuron cells treated with aloeemodin and neohesperidin, the increase of Ca 2+ influx was gentle and ended with a lower peak intensity. Albiflorin-treated cells showed the lowest intensity (about half of the control) suggesting that the calcium influx induced by Aβ was the most strongly attenuated by albiflorin. Albiflorin showed the highest effectiveness on maintaining the Ca 2+ level of hippocampal neuron cells. Each trace was an average of at least three independent measurements.
DISCUSSION
We have demonstrated for the first time that four compounds isolated from Chinese herbal medicines, namely albiflorin, aloeemodin, neohesperidin and physcion exhibit remarkable inhibitory effect against Aβ and Aβ 1-42 aggregation. Albiflorin, aloeemodin and neohesperidin also show the ability to reduce neurotoxicity induced by Aβ species on primary hippocampal neuronal cells. To obtain insight into the AD disease mechanism, the influence of these three neuroprotective CHM compounds on the oxidative stress and intracellular Ca 2+ ion concentration were investigated. The compounds were found to be able to effectively attenuate ROS generation induced by Aβ species. These findings are attributed to the fact that these CHM compounds are anti-oxidant and anti-inflammatory in nature. Moreover, albiflorin can remarkably maintain intracellular Ca 2+ ion level upon Aβ attack. Thus, these three active and non-toxic CHM compounds that can (i) inhibit the Aβ aggregation formation;
(ii) protect cells against toxicity induced by reactive oxygen species and; (iii) reduce Ca 2+ ion influx induced by Aβ species are promising candidates to prevent and treat AD. Our study here strongly supports further in-vivo investigation on the clinical potential of these three CHM compounds, in particular their brain bioavailability, pharmacokinetics and capability in cognitive improvement in AD models.
